SEVERINO MICHAEL
SEC CIK 1609447 · EDGAR
BoughtSold
Most active insiders at SRPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Estepan Ian Michael | COO | — | $294.2K |
| 2 | Mayo Stephen | Dir | — | $123.2K |
| 3 | Wong Ryan Ho-Yan | CFO | — | — |
| 4 | Rothfuss Cristin | EVP, GC | — | — |
| 5 | Chambers Michael Andrew | Dir | — | — |
| 6 | Rodino-Klapac Louise | Pres, R, D, Tech Ops | — | — |
| 7 | Boor Kathryn Jean | Dir | — | — |
| 8 | Nicaise Claude | Dir | — | — |
| 9 | SEVERINO MICHAEL | CEO, Dir | — | — |
| 10 | Barry Richard | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-29 20:05 | 2026-07-28 | SRPT | Sarepta Therapeutics, Inc. | SEVERINO MICHAEL | CEO, Dir | A - Grant | — | +756.1K | 756.1K | New | — |
| 2026-05-11 16:38 | 2026-05-07 | AVTR | Avantor, Inc. | SEVERINO MICHAEL | Dir | A - Grant | $0.00 | +25.3K | 85.8K | +42% | $0 | |
| DM | 2026-03-10 | 2026-03-06 | VTRS | Viatris | SEVERINO MICHAEL | Dir | M - OptEx | $0.00 | +26.0K | 26.0K | New | $0 |
| 2025-05-12 | 2025-05-08 | AVTR | Avantor, Inc. | SEVERINO MICHAEL | Dir | A - Grant | $0.00 | +17.1K | 60.6K | +39% | $0 | |
| 2024-05-13 | 2024-05-09 | AVTR | Avantor, Inc. | SEVERINO MICHAEL | Dir | A - Grant | $0.00 | +8,477 | 43.5K | +24% | $0 | |
| 2023-05-15 | 2023-05-11 | AVTR | Avantor, Inc. | SEVERINO MICHAEL | Dir | A - Grant | $0.00 | +9,808 | 35.0K | +39% | $0 | |
| DM | 2022-05-25 | 2022-05-23 | ABBV | AbbVie | SEVERINO MICHAEL | Vice COB | M - OptEx | $108.99 | +79.8K | 231.9K | +52% | +$8.70M |
| DM | 2022-05-25 | 2022-05-23 | ABBV | AbbVie | SEVERINO MICHAEL | Vice COB | S - Sale+OE | $150.90 | -79.8K | 152.1K | -34% | -$12.04M |
| DM | 2022-05-18 | 2022-05-16+ | ABBV | AbbVie | SEVERINO MICHAEL | Vice COB | S - Sale+OE | $154.25 | -200.0K | 152.5K | -57% | -$30.85M |
| DM | 2022-05-18 | 2022-05-16+ | ABBV | AbbVie | SEVERINO MICHAEL | Vice COB | M - OptEx | $77.44 | +200.0K | 223.0K | +870% | +$15.49M |
| 2022-05-16 | 2022-05-12 | AVTR | Avantor, Inc. | SEVERINO MICHAEL | Dir | A - Grant | $0.00 | +6,693 | 25.2K | +36% | $0 | |
| DM | 2022-05-10 | 2022-05-06+ | ABBV | AbbVie | SEVERINO MICHAEL | Vice COB | M - OptEx | $56.79 | +300.0K | 252.1K | New | +$17.04M |
| DM | 2022-05-10 | 2022-05-06+ | ABBV | AbbVie | SEVERINO MICHAEL | Vice COB | S - Sale+OE | $151.12 | -300.0K | 229.2K | -57% | -$45.34M |
| 2022-04-05 | 2022-04-01 | AVTR | Avantor, Inc. | SEVERINO MICHAEL | Dir | A - Grant | $0.00 | +1,215 | 18.5K | +7% | $0 | |
| 2022-03-01 | 2022-02-25 | ABBV | AbbVie | SEVERINO MICHAEL | Vice COB | F - Tax | $149.54 | -38.9K | 152.1K | -20% | -$5.81M | |
| DM | 2022-02-22 | 2022-02-17 | ABBV | AbbVie | SEVERINO MICHAEL | Vice COB | A - Grant | $0.00 | +87.7K | 161.9K | +118% | $0 |
| 2021-12-30 | 2021-12-27 | ABBV | AbbVie | SEVERINO MICHAEL | Vice COB | G - Gift | $0.00 | -583 | 103.3K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations